Alex Sparreboom is a Professor in the Division of Pharmaceutics at the Ohio State University in Columbus, OH. He received his BSc (1989), MSc (1993), and PhD (1996) in Pharmacy from Utrecht University (Utrecht, the Netherlands), and he was previously affiliated with the Daniel den Hoed Cancer Center at Erasmus University (Rotterdam, the Netherlands), the National Cancer Institute (Bethesda, MD), and St. Jude Children’s Research Hospital (Memphis, TN). Alex Sparreboom has published over 300 peer-reviewed articles and 20 book chapters (h-index, 85). He is presently Senior Editor of Clinical Cancer Research and Associate Editor of Clinical Pharmacology & Therapeutics, and has previously served on the scientific program committees of the annual meetings of AACR, ASCPT, and ASCO. His current research interests focus on the role of solute carriers in anticancer drug disposition and toxicity, and his laboratory is funded by grants from the National Cancer Institute, NIH. His avocations include eating cheese while listening to late-medieval polyphony, and collecting books on the Simon-Le Clerc controversy.